Position in RCKT
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$963,757
+$559,528 QoQ
Shares Held
269,206
+133.8% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RCKT Over Time
Shares Held
Position Value (USD)
Derivatives in RCKT
reported options exposure · as of Sep 30, 2024CallValue
$6,778
CallShares
367
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $2,945,837,016 across 415 Biotechnology names. RCKT ranks #122 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
448,371 | $346,429,369 | |
| 2 | MRNA |
Moderna, Inc.
|
4,317,219 | $219,314,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
415,625 | $185,593,187 | |
| 4 | BNTX |
BioNTech SE
|
1,651,789 | $146,811,006 | |
| 5 | ARGX |
Argenx SE
|
177,836 | $129,864,739 | |
| 6 | INSM |
INSMED Inc
|
604,600 | $98,864,192 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,307,176 | $97,070,889 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
280,965 | $92,962,889 |
All Filings in RCKT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $963,757 | 269,206 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $404,229 | 115,165 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,230,923 | 377,584 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,113,868 | 454,640 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $893,072 | 133,894 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,991,578 | 158,439 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,778 | 367 | Call | Defined | 2024-11-13 | |
| 2024-09-30 | $719,535 | 38,957 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $237,755 | 11,043 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,145,973 | 42,538 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $2,595,012 | 86,587 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,260,257 | 61,506 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,002,123 | 50,434 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $2,040,576 | 119,123 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,122,222 | 57,344 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,949,232 | 184,789 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $239,107 | 17,377 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $986,254 | 62,185 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $1,021,491 | 46,793 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $286,136 | 9,573 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $5,361,038 | 121,044 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $405,231 | 9,133 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $291,529 | 5,316 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $195,247 | 8,541 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $71,873 | 3,434 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $172,770 | 12,385 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||